A.O. Smith Corp. (AOS) Tops Q4 EPS by 4c; Guides FY12 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts AOS Hot Sheet
Price: $63.07 -0.06%
Financial Fact:
Net Earnings attributable to A. O. Smith Corporation: 0.47
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Net Earnings attributable to A. O. Smith Corporation: 0.47
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
A.O. Smith Corp. (NYSE: AOS) reported Q4 EPS of $0.68, $0.04 better than the analyst estimate of $0.64. Revenue for the quarter came in at $475.8 million versus the consensus estimate of $460.39 million.
A.O. Smith Corp. sees FY2012 EPS of $2.65-$2.85, versus the consensus of $2.83.
For earnings history and earnings-related data on A.O. Smith Corp. (AOS) click here.
A.O. Smith Corp. sees FY2012 EPS of $2.65-$2.85, versus the consensus of $2.83.
For earnings history and earnings-related data on A.O. Smith Corp. (AOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
